Epigenetics in human disease and prospects for epigenetic therapy

被引:2320
作者
Egger, G
Liang, GN
Aparicio, A
Jones, PA
机构
[1] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA
[2] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Urol, Los Angeles, CA 90089 USA
关键词
D O I
10.1038/nature02625
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'-several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 97 条
  • [1] Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
    Amir, RE
    Van den Veyver, IB
    Wan, M
    Tran, CQ
    Francke, U
    Zoghbi, HY
    [J]. NATURE GENETICS, 1999, 23 (02) : 185 - 188
  • [2] Syndromes of disordered chromatin remodeling
    Ausió, J
    Levin, DB
    de Amorim, GV
    Bakker, S
    Macleod, PM
    [J]. CLINICAL GENETICS, 2003, 64 (02) : 83 - 95
  • [3] Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
    Bachman, KE
    Park, BH
    Rhee, I
    Rajagopalan, H
    Herman, JG
    Baylin, SB
    Kinzler, KW
    Vogelstein, B
    [J]. CANCER CELL, 2003, 3 (01) : 89 - 95
  • [4] A rheostat model for a rapid and reversible form of imprinting-dependent evolution
    Beaudet, AL
    Jiang, YH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (06) : 1389 - 1397
  • [5] Belinsky SA, 2003, CANCER RES, V63, P7089
  • [6] Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
    Cameron, EE
    Bachman, KE
    Myöhänen, S
    Herman, JG
    Baylin, SB
    [J]. NATURE GENETICS, 1999, 21 (01) : 103 - 107
  • [7] CARCINOGENICITY AND HEMOGLOBIN-SYNTHESIS INDUCTION BY CYTIDINE ANALOGS
    CARR, BI
    RAHBAR, S
    ASMERON, Y
    RIGGS, A
    WINBERG, CD
    [J]. BRITISH JOURNAL OF CANCER, 1988, 57 (04) : 395 - 402
  • [8] Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2
    Chen, WG
    Chang, Q
    Lin, YX
    Meissner, A
    West, AE
    Griffith, EC
    Jaenisch, R
    Greenberg, ME
    [J]. SCIENCE, 2003, 302 (5646) : 885 - 889
  • [9] Inhibition of DNA methylation and reactivation of silenced genes by zebularine
    Cheng, JC
    Matsen, CB
    Gonzales, FA
    Ye, W
    Greer, S
    Marquez, VE
    Jones, PA
    Selker, EU
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (05) : 399 - 409
  • [10] Epigenetic targets in hematopoietic malignancies
    Claus, R
    Lübbert, M
    [J]. ONCOGENE, 2003, 22 (42) : 6489 - 6496